Beijing Shijitan Hospital
Beijing, Beijing Municipality, 100038, China
Location status: Recruiting
Location contact
Jian-Xin Zhou, MD, PhD
CONTACT
Shan-Shan Xu, MD
CONTACT
NCT Number: NCT06816706
Spontaneous breathing trials (SBT) are essential for assessing extubation tolerance, yet optimal approaches are debated. High-flow nasal oxygen offers benefits like precise oxygen delivery, flow-related positive end-expiratory pressure generation and improved lung function. While high-flow tracheal oxygen can also be used as an SBT method, it has reduced physiological effects due to bypassing the upper airway with a more open circuit. To enhance this limitation, investigators developed a modified high-flow tracheal oxygen tube with a smaller expiratory end diameter to increase expiratory resistance and airway pressure. This is a prospective randomized crossover study that aims to compare the physiological effects of standard and modified high-flow tracheal oxygen versus T-piece during SBT.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100038, China
Location status: Recruiting
Jian-Xin Zhou, MD, PhD
CONTACT
Shan-Shan Xu, MD
CONTACT
A spontaneous breathing trial (SBT) is a crucial step in the weaning and extubation process for assessing extubation tolerance. However, the optimal approach for conducting SBTs remains a topic of debate.
High-flow nasal oxygen has been shown to provide several physiological benefits, including precise control of the fraction of inspired oxygen, generation of flow-related positive end-expiratory pressure, increased end-expiratory lung volume, improved oxygenation, and enhanced carbon dioxide elimination. High-flow oxygen therapy can also be applied via an artificial airway as high-flow tracheal oxygen. Previous studies have identified this therapy as a potential alternative for SBTs. However, compared to high-flow nasal oxygen, high-flow tracheal oxygen exhibits significantly diminished physiological effects due to the bypassing of the narrow nasopharynx, glottis, and upper airway as well as a more open circuit.
To address this limitation, the investigators have developed a modified high-flow tracheal oxygen tube with a reduced expiratory end tube diameter. This modification aims to create higher expiratory resistance and airway pressure, thereby simulating the physiological effects of HFNC. This study is a prospective randomized crossover physiological study designed to compare the effects of standard and modified high-flow tracheal oxygen versus T-piece during spontaneous breathing trials. Key physiological parameters will be assessed, including airway pressure, end-expiratory lung volume, vital signs, oxygenation, and respiratory workload.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Modified high-flow tracheal oxygen with a flow rate of 40L/min will be performed.
Standard high-flow tracheal oxygen with a flow rate of 40 L/min will be performed.
T-piece will be performed.
Modified high-flow tracheal oxygen with a flow rate of 60L/min will be performed.
Standard high-flow tracheal oxygen with a flow rate of 60 L/min will be performed.
Time frame: From enrollment to the end of treatment at 4 hours
Mean expiratory airway pressure will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Positive end-expiratory pressure will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Change of end-expiatory lung volume will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Respiratory rate will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Tidal volume will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
End-tidal carbon dioxide will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Pulse oxygen saturation will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Esophageal pressure-time product will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Tidal swing of esophageal pressure will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Respiratory muscle pressure will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Time frame: From enrollment to the end of treatment at 4 hours
Dynamic transpulmonary pressure will be measured during standard and modified high-flow tracheal oxygen versus T-piece.
Contact information is provided by the study sponsor or research team.
Jian-Xin Zhou, MD, PhD
CONTACT
Shan-Shan Xu, MD
CONTACT
Jian-Xin Zhou
Other
Comparison of Physiological Effects of Two Types of High-Flow Tracheal Oxygen Versus T-Piece During Spontaneous Breathing Trials in Mechanically Ventilated Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07093125
Critical Care, Extubation Failure
Genova, Italy
View Trial DetailsNCT06042621
Acute Respiratory Failure, Behavior
Chicago, Illinois, United States
View Trial DetailsNCT06968793
Critical Care, Inspiratory Effort
Beijing, Beijing Municipality, China
View Trial DetailsNCT06816745
Critical Care, Oxygen Therapy
Beijing, Beijing Municipality, China
View Trial Details